Anzu-cel Plain Language Summary

Patient-level Clinical Response Dynamics in Advanced Melanoma With Anzu-cel, a PRAME-targeted TCR T-cell Therapy

Phase 1 Trial Results with PRAME-targeted T-cell Receptor (TCR) T-cell Therapies in Synovial Sarcoma

Phase 1 Trial Results for IMA203CD8, a PRAME-Targeted T-cell Receptor (TCR) T-cell Therapy, in Ovarian Cancer

IMA203CD8 Plain Language Summary

First-in-Human Results With IMA401, a MAGEA4/8-targeted T-cell Receptor-based Bispecific T-cell Engager (TCER), in Recurrent or Refractory Solid Tumors